Join TriSalus Life Sciences for a virtual key opinion leader (KOL) event featuring Alexander S. Misono, MD, MBA, RPVI (Chief of Interventional Radiology, Hoag Hospital, Newport Beach, CA), who will join company management to discuss the unmet need and current treatment landscape primary liver tumors and liver metastases.

The event will highlight results from a newly published real-world outcomes study comparing PEDD™ and non-PEDD™ embolization approaches in patients undergoing TACE and TARE. Dr. Misono will discuss how the findings influence treatment strategy, considerations for patient selection, and share clinical experience and case examples using the TriNav Infusion System.

A live question and answer session will follow the formal presentations.